OSENVELT FDA approval date

The FDA approved OSENVELT on 28 Feb 2025.

FDA approval date
28 Feb 2025

Drug identity has not yet been verified against registry records

Also recorded as DENOSUMAB-BMWO

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-02-28DayOSENVELTFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761404", "applicant_as_listed_by_fda": "CELLTRION INC", "brand_names": ["OSENVELT", "STOBOCLO"], "active_ingredients": ["DENOSUMAB-BMWO"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20250228", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026